| Issue Date | Title | Author(s) |
| 2022-06-01 | Association of Low-Dose Triple Combination Therapy vs Usual Care With Time at Target Blood Pressure: A Secondary Analysis of the TRIUMPH Randomized Clinical Trial | Gnanenthiran, SR; Wang, N; DiTanna, GL; Salam, A; Webster, R; DeSilva, HA; Guggilla, R; Jan, S; Maulik, PK; Naik, N; Selak, V; Thom, S; Prabhakaran, D; Schutte, AE; Patel, A; Rodgers, A |
| 2021-01-01 | Effects of Low-dose Triple Combination Therapy on Time at Target Blood Pressure – Results From the TRIUMPH Randomized Controlled Trial | Gnanenthiran, S; Wang, N; Salam, A; Webster, R; de Silva, A; Schutte, A; Patel, A; Rodgers, A |
| 2020-11 | Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH Trial. | Wang, N; Salam, A; Webster, R; de Silva, A; Guggilla, R; Stepien, S; Mysore, J; Billot, L; Jan, S; Maulik, PK; Naik, N; Selak, V; Thom, S; Prabhakaran, D; Patel, A; Rodgers, A; TRIUMPH Study Group |
| 2019-10-01 | Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial | Lung, T; Jan, S; de Silva, HA; Guggilla, R; Maulik, PK; Naik, N; Patel, A; de Silva, AP; Rajapakse, S; Ranasinghe, G; Prabhakaran, D; Rodgers, A; Salam, A; Selak, V; Stepien, S; Thom, S; Webster, R; Lea-Laba, T |
| 2018-08-01 | Process evaluation of a randomised controlled trial of a pharmacological strategy to improve hypertension control: Protocol for a qualitative study | Salam, A; Webster, R; Patel, A; Godamunne, P; Pathmeswaran, A; De Silva, HA; Rogers, A; Jan, S; Laba, TL |
| 2018-07-01 | Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trial. | Singh, K; Crossan, C; Laba, T-L; Roy, A; Hayes, A; Salam, A; Jan, S; Lord, J; Tandon, N; Rodgers, A; Patel, A; Thom, S; Prabhakaran, D |
| 2017-03-11 | Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review. | Chow, CK; Thakkar, J; Bennett, A; Hillis, G; Burke, M; Usherwood, T; Vo, K; Rogers, K; Atkins, E; Webster, R; Chou, M; Dehbi, H-M; Salam, A; Patel, A; Neal, B; Peiris, D; Krum, H; Chalmers, J; Nelson, M; Reid, CM; Woodward, M; Hilmer, S; Thom, S; Rodgers, A |
| 2015-11-09 | Behaviour change strategies for reducing blood pressure-related disease burden: findings from a global implementation research programme. | GACD Hypertension Research Programme, Writing Group; Peiris, D; Thompson, SR; Beratarrechea, A; Cárdenas, MK; Diez-Canseco, F; Goudge, J; Gyamfi, J; Kamano, JH; Irazola, V; Johnson, C; Kengne, AP; Keat, NK; Miranda, JJ; Mohan, S; Mukasa, B; Ng, E; Nieuwlaat, R; Ogedegbe, O; Ovbiagele, B; Plange-Rhule, J; Praveen, D; Salam, A; Thorogood, M; Thrift, AG; Vedanthan, R; Waddy, SP; Webster, J; Webster, R; Yeates, K; Yusoff, K; Hypertension Research Programme members |
| 2013-06-06 | INterpreting the Processes of the UMPIRE Trial (INPUT): Protocol for a qualitative process evaluation study of a fixed-dose combination (FDC) strategy to improve adherence to cardiovascular medications | Salam, A; Stewart, F; Singh, K; Thom, S; Williams, HJ; Patel, A; Jan, S; Laba, T; Prabhakaran, D; Maulik, P; Day, S; Ward, H |
